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Summary
AIM OF THE STUDY: The aim of this multicentre,
prospective, open, nonrandomised clinical trial was to
demonstrate the clinical efficiency and outcomes of
cochlear implants (CIs) in adult patients with post-lingual
single-sided deafness (SSD).
METHODS: A group of five left and five right SSD par-
ticipants were investigated with various clinical tests and
questionnaires before and 12 months after CI activation.
Changes in hearing thresholds, speech understanding in
noise, sound localisation, tinnitus (Tinnitus Handicap In-
ventory; THI), subjective hearing ability (Speech, Spatial
and Qualities of Hearing Scale; SSQ), and quality of life
(WHOQOL-BREF) were assessed. In addition, the pre-
and postoperative results of the SSD patients were com-
pared with an age- and gender-matched normal hearing
control group.
RESULTS: Surgery was uncomplicated in all patients. Two
years after implantation, 9 of the 10 patients used their CI
regularly for an average of more than 11 hours a day. A
significant improvement in speech understanding in noise
measured in the sound field using the Oldenburg sentence
test could be demonstrated in the two situations in which
patients with SSD experience the greatest difficulty:
speech from the front and noise at the healthy ear, and
speech to the implanted ear and noise from the front. The
sound localisation test showed significant improvement of
the mean localisation error and the root mean square er-
ror after CI activation. Furthermore, a significant reduction
of the THI was measured, and the SSQ showed a sig-
nificant improvement in the subscale speech comprehen-
sion and in the subscale spatial hearing. Also, quality of
life measured with the WHOQOL-BREF showed a gener-
al improvement, which was significant in the global sub-
scale. For this questionnaire, there was no significant dif-
ference between the normal-hearing control group and the
patients after 12 months of CI use.
CONCLUSION: This study confirmed the clinical benefit of
cochlear implantation in patients with SSD. The significant
improvement of speech understanding in noise, sound lo-
calisation, tinnitus perception, subjective hearing ability,
and in particular the improved quality of life support the
recommendation that patients with recently acquired SSD
should be offered a CI. (Clinical trial registration number
on clinicaltrial.gov: NCT01749592)
Keywords: unilateral hearing loss, postoperative use of
cochlear implant, quality of life, tinnitus, sound localisa-
tion, speech understanding in noise, speech reception in
noise, normal hearing control group
Introduction
Single-sided deafness (SSD) is a type of hearing impair-
ment in which the patient has normal hearing in one ear
and severely impaired hearing in the other ear. By consen-
sus, SSD is defined as a mean pure-tone hearing thresh-
old (averaged over 0.5, 1, 2 and 4 kHz) of at least 70 dB
hearing level (HL) in the poorer and not more than 30 dB
HL in the better ear [1]. Post-lingual SSD can occur for
different reasons. A common cause is sudden sensorineur-
al hearing loss (SSNHL). Other causes, such as Menière’s
disease, unilateral vestibular schwannoma, or infections
(e.g., labyrinthitis, mumps, meningitis), and trauma such
as temporal bone fractures, iatrogenic hearing loss after
ear surgery or unilateral noise damage are more rarely in-
volved [2].
SSD often has a significant impact in communication skills
owing to impaired sound localisation and decreased speech
understanding in noise. Hearing loss is also a general risk
factor for the development of tinnitus [3–7], and 73 to 84%
of patients with SSNHL experience it [8–13], with 29%
having a moderate to severe level of tinnitus handicap [9].
The traditional rehabilitation of SSD consists of hearing
systems with routing of acoustic signals from the deaf ear
to the healthy normal hearing ear, such as hearing aids with
contralateral routing of signals (CROS) or bone-anchored
hearing aids (BAHAs). These hearing systems overcome
the head shadow, but they do not reliably improve sound
localisation [14]. Contradictory findings with small effects
on speech understanding in noise were reported in the lit-
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erature [15–22]. In addition, they do not usually reduce or
suppress the perception of tinnitus [15].
Several theoretical models assume that a lesion of the
cochlear hair cells induces a suboptimal or maladaptive
plasticity of the central nervous system, which also induces
the perception of tinnitus [23–29]. Consequently, restoring
hearing by cochlear implantation may affect tinnitus per-
ception [30]. Under this assumption, Van de Heyning et al.
were the first to provide a group of patients with post-lin-
gual SSD and severe to profound tinnitus with cochlear im-
plants (CIs) [31]. This and following studies demonstrated
that CI implantation is an effective treatment for tinnitus in
patients with SSD [15, 30–39], even though a small portion
of patients experienced deterioration of tinnitus after CI
surgery [30, 40]. Further studies demonstrated an improve-
ment of speech understanding in noise and sound localisa-
tion after CI implantation in patients with SSD along with
the tinnitus reduction [15–17, 22, 33–35, 39, 41–50]. Many
additional studies have demonstrated the clinical benefits
of CI implantation in patients with SSD by using ques-
tionnaires [33, 34, 44, 45, 51–54]. However, some studies
have included not only patients with SSD but also those
with asymmetrical hearing loss [30, 43, 45, 51]. Addition-
al studies with carefully selected and well documented pa-
tients are still needed to substantiate the benefit of CI in
SSD. Such studies may also contribute to reliable meta-
analyses in the future.
The aim of this study was to replicate, investigate and doc-
ument the effects of CI implantation in adults with post-
lingual SSD in Switzerland, and to evaluate the function-
al adaptions using speech understanding in noise, sound
localisation, tinnitus assessment and quality of life ques-
tionnaires. In addition, the pre- and postoperative results
of the SSD patients were compared with an age- and gen-
der-matched normal hearing control group. Our hypothesis
was that these patients profit consistently from CI provi-
sion through improved hearing, tinnitus reduction and im-
proved quality of life.
Materials and methods
Study design and participants
From 2012 to 2016, we performed a multicentre (Universi-
ty Otorhinolaryngology Departments of Zurich and Bern),
prospective, open, nonrandomised clinical trial with the se-
quential enrolment of five patients with left and five pa-
tients with right SSD. SSD was defined as a hearing loss of
≥70 dB HL in the mean thresholds of 0.5, 1, 2 and 4 kHz
in the affected ear, and 25 dB HL or better in the frequen-
cies from 125 to 2 kHz and 35 dB HL or better from 4 to 8
kHz in the normally hearing contralateral ear. The patients
had to fulfil the following inclusion criteria: age between
18 and 70 years; acquired SSD due to cochlear damage;
normal structure of the cochlea and the cochlear nerve on
magnetic resonance imaging (MRI); onset of SSD within
6 months to 10 years before study inclusion; impairment
of daily life as a consequence of SSD; and unsatisfactory
benefit from a trial of a conventional acoustic hearing aid
(CROS or BAHA). Patients were excluded when they had
middle ear pathology of one ear, psychiatric comorbidity
such as depression or cognitive deficits, or severe coexist-
ing illness. To compare the 10 patients with a normal hear-
ing control group, 10 age-, and gender-matched, healthy
participants were included in the study. These participants
had normal hearing in both ears (hearing thresholds from
0.125 to 2 kHz 25 dB HL or better and from 4 to 8 kHz 35
dB HL or better). All study participants gave their written
informed consent before undergoing the study procedure.
The study was approved by the local institutional review
boards (reference numbers KEK-ZH 2012-0034 and KEK-
BE 233/12).
Outcome measures
Pure-tone and sound field audiometry
Hearing thresholds were measured before CI implantation
using insert earphones at 0.125, 0.25, 0.5, 1, 2, 3, 4, 6
and 8 kHz for air conduction, and at 0.25, 0.5, 1, 2, 3 and
4 kHz for bone conduction. Appropriate masking of the
healthy ear was applied for threshold measurements of the
deaf ear. Thresholds exceeding the assessment limits of the
audiometer were recorded as 120 dB HL. Binaural hear-
ing thresholds were measured using wobble tone stimuli in
the sound field. Twelve months after CI activation, pure-
tone audiometry was repeated using insert earphones in the
normal hearing ear. For the implanted ear, the sound field
hearing thresholds were assessed with the normal hearing
ear plugged and muffed. Pure-tone audiometry was per-
formed only once in the normal hearing control partici-
pants.
Transiently evoked otoacoustic emissions
Transiently evoked otoacoustic emissions (TEOAE) were
measured on both ears before implantation using standard
clinical equipment. The measurements were repeated 3
months after the CI activation. Normal hearing participants
were tested only once.
Speech understanding in noise
All sound field experiments were performed inside an
acoustically treated chamber (6 × 4 × 2 m3) with a rever-
beration time of approximately 200 ms for frequencies be-
tween 0.25 and 10 kHz. We assessed speech understanding
in noise using the Oldenburg sentence test, a standardised
adaptive German matrix test [55]. The speech reception
threshold, expressed as the signal-to-noise ratio at which
50% of the words are correctly understood, was measured
with 30 sentences per trial. The background noise (speech
babble noise) was presented at a fixed level of 65 dB sound
pressure level (SPL) and the level of the speech signals
was adapted according to the participant’s response. The
tests were performed in five different spatial configura-
tions (fig. 1): (i) speech and noise from the front (S0N0),
(ii) speech from the front, noise to the contralateral (nor-
mal hearing) ear (S0NCL), (iii) speech to the ipsilateral (im-
planted) ear, noise from the front (SIPN0), (iv) speech from
the front, noise to the ipsilateral (implanted) ear (S0NIP),
and (v) speech to the contralateral (normal hearing) ear and
noise from the front (SCLN0). These test situations were
chosen to enable the assessment of the binaural summation
effect (S0N0 unaided vs aided condition), the squelch ef-
fect (S0NIP unaided vs aided condition), the head shadow
effect (SIPN0 unaided vs aided condition) and spatial re-
lease from masking (S0N0 aided vs S0NIP aided) [44]. For
these measures, positive values indicate binaural benefit.
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Before testing, two training tests were performed. The or-
der of the test conditions, spatial configurations and test
lists were systematically varied to minimise bias. The tests
were performed preoperatively and 12 months after the CI
activation on all patients and once on the normal hearing
participants. Additionally, the S0N0 test was performed 3
and 6 months after CI activation.
Sound localisation
Sound localisation was assessed using 12 speakers
arranged in a horizontal circle at 1.2 m height with a radius
of 1 m and an angular resolution of 30°. Participants were
seated in the centre of the array. Three white noise stimuli
of 200-ms duration were presented in a random order from
each speaker in a roving pattern (levels between 65 and 70
dB SPL), totalling 36 stimuli in each test condition. Rov-
ing was used to reduce any hints for localisation that could
be caused by acoustic characteristics of the loudspeakers.
Each of the loudspeakers were labelled with a number ac-
cording to a clock face. The participants verbally indicated
the number associated with the location of the loudspeak-
er that was the presumed source of the stimulus. Before
testing, the participants underwent a 5-minute training ses-
sion. The participants were instructed to keep their head
fixed to the frontal direction during stimulus presentation
and correct head position was monitored by the examin-
er. No feedback on results was provided during or after
the test procedures. The mean absolute localisation error
(in degrees) and the root mean square error (in degrees)
between the azimuthal positions of the stimulus speaker
and the indicated speaker were assessed. This test was per-
formed preoperatively and 12 months after the CI activa-
tion on all patients and once on the normal hearing partic-
ipants. The chance level of this test setup was 90° for the
mean absolute localisation error corresponding to 104.6°
when expressed as root mean square error.
Questionnaires
To assess tinnitus severity, we used the Tinnitus Handicap
Inventory (THI) [56]. The validated German version [57]
contains 25 questions with three response options (yes – 4
points; sometimes – 2 points; no – 0 points). Consequently,
the THI total score ranges from zero to 100 and indicates
the subject’s overall handicap related to tinnitus [58]. The
total score can be divided into five categories of tinnitus
severity: slight (0–16), mild (18–36), moderate (38–56),
severe (58–76), and catastrophic (78–100) [59].
The validated questionnaire World Health Organization
Quality of Life Short Form Survey (WHOQOL-BREF)
was used to measure health-related quality of life [60].
The WHOQOL-BREF consists of 26 items assessing the
following broad domains: physical health, psychological
health, social relationships, environment and global quality
of life [58]. Generally, a higher value in every domain rep-
resents a better quality of life.
The German version of the standardised Speech, Spatial
and Qualities of Hearing Scale questionnaire (SSQ, Ver-
sion 5.6 [61–63]) was used to measure the improvement
of hearing ability in various environmental conditions of
everyday life after CI implantation. The questionnaire con-
tains three parts in which speech comprehension, spatial
hearing and qualities of hearing are measured. The ques-
tionnaire consists of 19 questions, which are answered on
a Likert scale from 0 (complete disability) to 10 (complete
ability). It follows that the higher the score in each part of
the SSQ, the better the respective ability.
The patients were asked to fill in all questionnaires preop-
eratively and 12 months after activation. Normal hearing
participants answered the SSQ and WHOQOL-BREF
questionnaire only once.
Statistical analysis
Descriptive statistics were calculated and mean values with
standard deviations (SDs) are presented. Two-sided paired
t-tests were used to compare the following preoperative
and postoperative aided outcome measures: speech recep-
tion thresholds for each speech in noise configuration,
mean absolute and root mean square localisation errors,
and minimum audible angle. To test whether speech re-
ception threshold changed over time in the S0N0 situation,
a repeated measures analysis of variance (ANOVA) was
performed. WHOQOL-BREF scores were compared using
paired t-tests with adjusted p-values using a Bonferroni
correction. Differences in audiological outcomes between
the implanted subjects and the normal hearing group were
not statistically tested. The level of significance was set at
p ≤0.05. Graphical representations and statistical analyses
of the data were performed using the Prism software pack-
age (GraphPad Software Inc, US; version 6.0).
Figure 1: Test settings for speech understanding in noise. S0N0: speech and noise from the front; S0NCL: speech from the front, noise to the
contralateral (normal hearing) ear; SIPN0: speech to the ipsilateral (implanted) ear, noise from the front; S0NIP: speech from the front, noise to
the ipsilateral ear; SCLN0: speech to the contralateral ear and noise from the front. Gray speaker = noise, white speaker = speech, black rec-
tangle = implant position.
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Results
Participants
From November 2012 to May 2016, 54 candidates with
post-lingual SSD fulfilling the inclusion criteria were
asked to participate in the study. Forty-four of them de-
clined to take part, mostly because of the invasiveness of
cochlear implantation, too little impairment in daily life,
aesthetic concerns with the clearly visible speech proces-
sor, lack of motivation for hearing rehabilitation, or suffi-
cient benefit with a conventional hearing aid fitting (CROS
or BAHA). The 10 patients (4 women) included had a
mean age of 47 years (range 27.8–62.7, SD 10.2). The
mean duration of SSD before the inclusion date was 1.3
years (range 0.5–4.3, SD 1.1) and before CI implantation
1.7 years (range 0.8–4.6, SD 1.1). Five patients had in-
volvement on the left side (two women; mean age 44.3
years, SD 10.3) and five on the right (two women; mean
age 49.6 years, SD 10.4). The mean time between CI im-
plantation and CI activation was 4 weeks (SD 1 week). The
cause of the SSD was SSNHL in nine cases and herpes
zoster oticus in the other.
Preoperative measurements of TEOAE confirmed the uni-
lateral deafness. The mean total otoacoustic response am-
plitude for the healthy right ears was 11.3 dB SPL and 7.8
dB SPL for the healthy left ears. The normal hearing con-
trol group showed mean total otoacoustic response ampli-
tudes of 7.6 dB SPL for the right ears and of 7.5 dB SPL
for the left. The mean preoperative pure-tone threshold re-
sults of the patients and the normal hearing control group
are displayed in figure 2.
Surgical treatment and fitting of CI
Before inclusion, every patient underwent an MRI to con-
firm normal structure of the cochlea and the cochlear
nerve. Surgery was uneventful in all patients. The surgeries
were performed by three experienced surgeons. A standard
retroauricular incision and a limited mastoidectomy with
a posterior tympanotomy were used for the CI surgery.
The round window was exposed and perforated either with
a needle or by an extended round window approach. A
Nucleus CI422 implant with Slim Straight electrode
(Cochlear Ltd.) was introduced. The subcutaneous stimu-
lator/receiver unit was fixed retroauricularly. The implant
function was confirmed after the electrode insertion using
telemetric assessment of electrically evoked nerve poten-
tials. There were no major surgical complications after the
CI implantations. The correct localisation of the electrode
array was confirmed with a postoperative X-ray or com-
puted tomography scan.
The CI was activated 31 days (SD 7.3) after surgery. The
CI fitting was performed by behavioural measurements
following standard clinical procedures. Initially, threshold
and comfortable levels were assessed individually for all
electrodes. When a stable map was achieved after several
months of CI use, the stimulation settings were verified
using a sweep at comfortable levels over several adjacent
electrodes and at levels of typically 25% of the dynamic
range.
The objective data logging of the CI system showed that
9 of the 10 patients were using their CIs frequently 24
months or later after the CI activation for a mean daily du-
ration of 11.2 hours (SD 2.5). One female patient used the
CI only sporadically for 14 months and later discontinued
its use completely because of insufficient benefit.
Pure-tone and sound field audiometry
No significant changes of the preoperative pure-tone air
conduction hearing thresholds of the healthy ears were not-
ed postoperatively. Six patients had residual hearing of
the affected ear preoperatively that was fully preserved in
three and partially preserved in two of them after surgery
(fig. 3). Sound field CI-aided thresholds (normal hearing
ear plugged and muffed) were substantially improved
Figure 2: Averaged preoperative masked pure-tone thresholds of the patients (left panel) and normal hearing control participants (right panel).
Data are shown as mean and standard deviation.
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when compared with the preoperative pure-tone air con-
duction hearing thresholds of the SSD ears (fig. 4).
Speech understanding in noise
Figure 5 illustrates the speech reception thresholds (SRTs)
for the test situation S0N0 measured preoperatively, as well
as 3, 6, and 12 months post-activation. There were no sta-
tistically significant differences between group means as
determined by one-way ANOVA (F(3,27) = 0.451, p =
0.72). We did not observe an improvement of the SRTs
by binaural summation between the preoperative and the
12-month measurements (mean difference: −0.3 dB, SD
1.2 dB).
Figure 3: Pure-tone air conduction thresholds of the deaf ear mea-
sured with insert earphones 12 months after activation. The curves
marked in different shades of green represent hearing thresholds
of the patients with preserved residual hearing; the orange curves,
the averaged hearing thresholds of patients with partially pre-
served residual hearing; the red curve, the hearing thresholds of
the single patient with almost complete loss of residual hearing.
Figure 4: CI-aided sound field hearing thresholds assessed 12
months post activation with the normal ear plugged and muffed.
The average of all patients is indicated by the dashed black line.
Twelve months after CI activation, a significant improve-
ment in SRT in noise could be demonstrated in the two sit-
uations in which patients with SSD experience the most
difficulties (fig. 6): speech from the front and noise at
the healthy ear (S0NCL, 2.7 dB improvement, p = 0.0029);
and speech to the implanted ear and noise from the front
(SIPN0, 1.5 dB improvement, p = 0.018). Use of CI resulted
in an average squelch effect of 1.5 dB (SD 1.0), improve-
ment of the head shadow effect of 1.5 dB (SD 1.6), and
spatial release from masking of 3.0 dB (SD 1.9).
The participants in the normal hearing control group
achieved an average SRT of –8.9 dB (SD 2.2) in the S0N0,
–13.0 dB (SD 1.7) in the S0NCL, –13.0 dB (SD 2.0) in the
SIPN0, −12.3 dB (SD 2.2) in the S0NIP, and −12.8 dB (SD:
1.7) in the SCLN0 conditions.
Sound localisation
The mean localisation error of all participants was im-
proved by 10.2° (p = 0.030), and the root mean square error
by 12.2° (p= 0.029) 12 months after CI activation (fig. 7).
One participant lost low-frequency residual hearing from
the surgery, resulting in poorer localisation performance
after implantation with an increased error of 11.3°. All oth-
er participants either showed no differences or improve-
ment of their localisation accuracy. As expected, the par-
ticipants of the normal hearing control group had clearly
Figure 5: Speech reception threshold (SRT) in noise measured in
the sound field (S0N0) assessed preoperatively as well as 3, 6, and
12 months post activation.
Figure 6: Speech reception thresholds (SRTs) in noise measured
in the sound field preoperatively and 12 months after CI activation.
See figure 1 for a description of the tested spatial configurations. *
p <0.05; ** p <0.01.
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higher localisation accuracy with a mean absolute localisa-
tion error of 2.9° and root mean square error of 10.9°.
Tinnitus handicap
There was a significant reduction of tinnitus severity 12
months after CI activation. The mean THI value dropped
from 41.2 points (SD 26.5) preoperatively to 23.0 (SD
17.5) 12 months after CI activation. The paired t-test
showed a highly significant reduction of the THI (p =
0.004). The individual pre- and postoperative THI values
are displayed in figure 8. Four of the 10 patients suffered
from severe or catastrophic tinnitus preoperatively. They
all improved to a mild to moderate tinnitus postoperatively.
The values of patients with slight or mild tinnitus preop-
eratively showed a smaller postoperative improvement of
the tinnitus handicap. In summary, one patient demonstrat-
ed complete tinnitus suppression, seven patients reported
an improvement, and two patients had no change in tinni-
tus handicap. None experienced an increase of the percep-
tion of their tinnitus or its severity.
Quality of life
Quality of life also showed a general improvement, which
was significant in the global subscale of the WHOQOL-
BREF questionnaire (p = 0.007; fig. 9). In contrast to the
preoperative finding, there was no significant difference
between the normal hearing control group and the patients
after CI implantation (p = 0.71).
Speech, spatial and qualities of hearing scale
The SSQ results showed a significant improvement from
4.2 preoperatively to 6 postoperatively (p = 0.004) in the
subscale speech comprehension and from 3 to 5.3 (p =
0.009) in the subscale spatial hearing. There was no signif-
icant change in the subscale qualities of hearing from 6.2
preoperatively to 6.9 postoperatively (p = .13). The scores
of the patients on the three subscales were significantly
lower than for the normal hearing control group, with an
average speech comprehension of 8.7 (difference to the pa-
tient group p = 0.001), an average spatial hearing of 8.6
(difference p <0.001), and an average qualities of hearing
of 9.1 (difference p = 0.005).
Discussion
Recent literature has demonstrated that CI implantation in
SSD patients is a suitable hearing rehabilitation option. It
is the only option to restore binaural hearing [52]. This
study aimed to replicate the widely reported benefits of
Figure 7: Mean absolute (left) and root mean square (right) locali-
sation errors assessed preoperatively and 12 months post activa-
tion. * p <0.05.
CI implantation in adult patients with post-lingual SSD in
Switzerland and to investigate detailed objective and sub-
jective aspects using speech understanding in noise, sound
localisation, tinnitus assessment, quality of life and hearing
ability questionnaires. In addition, results of the SSD pop-
ulation were compared with an age- and gender-matched
Figure 8: Individual Tinnitus Handicap Inventory (THI) scores as-
sessed preoperatively and 12 months after activation.
Figure 9: Mean WHO Quality of Life (WHOQOL-BREF) scores of
the SSD patients assessed preoperatively and 12 months after ac-
tivation as well of the normal hearing control group (NHC).
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normal hearing cohort. Only a few studies have compared
selective results of speech understanding in noise [34, 39,
43, 64], sound localisation [34, 43, 52, 64], and subjective
hearing ability [39] with a normal hearing cohort, mostly
without control for age or gender matching.
Generally, our patients with SSD had a significant im-
provement in their quality of life 12 months after CI activa-
tion. Furthermore, we could demonstrate that their global
score on the WHOQOL-BREF questionnaire became com-
parable to that of the normal hearing control group. This
finding suggests that the patients with SSD had impaired
quality of life, which could be reversed by CI implantation.
Other studies used specific questionnaires regarding hear-
ing or hearing aids for the evaluation of quality of life [33,
45, 52, 54]. Härkönnen et al. [34] and Sladen et al. [54]
also used general health related quality of life question-
naires. Like us, Härkönnen et al. [34] showed significant
improvement of quality of life 6 months after CI activation
using the Glasgow Benefit Inventory. This study [34] al-
so demonstrated a significant improvement in the subscale
general health only. In contrast, the study by Sladen et al.
[54] showed no significant improvement in quality of life
through CI implantation in SSD patients using the SF-36
(Medical Outcomes Study Questionnaire Short Form 36)
questionnaire. An often-used questionnaire regarding qual-
ity of life in CI implantation is the Njimegen Cochlear Im-
plant Questionnaire (NCIQ), which has also shown a sig-
nificant improvement when applied to CI for SSD [45, 54].
Improvement in quality of life is likely to be a result of the
reduction in perceived tinnitus severity, and to improve-
ments in speech understanding in noise, spatial hearing,
and listening effort.
As with other studies [33, 34, 39, 49, 51, 52, 54, 65],
we used the SSQ to measure the improvement of hearing
ability in various environmental conditions. Several stud-
ies [16, 34, 65] have shown comparable results with sig-
nificant improvements in the subscale speech comprehen-
sion and spatial hearing, and nonsignificant improvement
in the subscale qualities of hearing. Other studies were able
to document a significant improvement in this subscale
as well [33, 39, 49, 52]. The reason for a less frequent-
ly significantly documented improvement in the qualities
of hearing subscale may be the normal hearing in the con-
tralateral ear.
As described for the first time by Van de Heyning et al.
[31], we could also demonstrate a significant reduction of
tinnitus severity 12 months after CI activation in our SSD
patients. Particularly, SSD patients with a high degree of
tinnitus severity improved considerably. Overall, eight pa-
tients reported a tinnitus reduction, two patients had stable
tinnitus, and none experienced an increase in the percep-
tion of their tinnitus. These results are comparable to oth-
er studies investigating tinnitus reduction after CI implan-
tation in SSD patients, as summarised in a recent review
[27].
A significant improvement of speech understanding in
noise could be demonstrated in two conditions 12 months
after CI activation: speech from the front and noise to the
healthy ear (S0NCL), and speech to the implanted ear and
noise from the front (SIPN0). Patients with SSD experience
the most difficulties in understanding speech in noise in
these situations. Cochlear implantation can improve these
conditions. Equally important, we did not observe a dete-
rioration of speech comprehension in the situations where
noise was closer to the implanted ear (S0NIP and SCLN0).
In a cohort of 45 SSD patients with CI assessed with the
Oldenburg sentence test, Arndt et al. [16] reported an im-
provement of approximately 7 dB in the test situation with
speech presented to the SSD side and noise to the normal
hearing side in a ±45° configuration. Our participants ex-
perienced an improvement of 1.5 to 2 dB in a 0/90° con-
figuration (S0NCL and SIPN0). Since the same test mater-
ial and procedural parameters were used, we assume that
the different test configuration (i.e., speakers from ±45° in-
stead of ±90°) was contributing to the difference in out-
comes. In addition, Arndt et al. [16] observed a small but
statistically significant summation effect of approximately
1 dB. A similar result was reported by Mertens et al. [45]
with a summation effect of 1.3 dB in a 12-month follow-up
of SSD patients. We did not reproduce these results in our
smaller cohort. We observed a small and statistically in-
significant squelch effect of 1.5 dB, which reproduces the
findings of Mertens et al. [45]. They found an effect size of
0.3 at the 12-month follow-up. The head shadow effect was
smaller (1.5 dB) than reported by Mertens et al. (3.0 dB)
[45]. We attribute this difference mainly to our test config-
uration, in which we presented noise closer to the normal
hearing ear than did Mertens et al. [45]. The result may re-
flect a partial bypass of the head shadow. Spatial release
of masking (3.0 dB) was similar to the effect measured by
Mertens et al. (4.7 dB) [45], indicating that our participants
could benefit from separated sound sources when using the
implant.
Finally, CIs significantly improved the sound localisation
abilities of the patients 12 months after activation, demon-
strating binaural information integration of the normal
hearing and the implanted ear. Impeded spatial hearing
abilities are usually among the major complaints of pa-
tients with SSD. A comparison with previous studies is dif-
ficult since widely variable test conditions have been used
with different numbers and spatial arrangements of loud-
speakers, different test stimulus levels and types, and dif-
ferent error quantification. The majority of previous stud-
ies have demonstrated a partial restoration of sound
localisation [32, 33, 36, 42, 43, 51]. However, comparisons
are difficult because of the above-mentioned differences,
and because patients’ characteristics, including the extent
of hearing preservation, can influence outcomes. In the fol-
lowing discussion, we will focus on relative improvements
of the localisation errors. The study of Hoth et al. [43] used
an identical measurement setup and showed a root mean
square localisation improvement of 25°, which is twice as
much as in our study (12.2°). We believe that the high-
er improvement reported by Hoth et al. [43] was because
speech material was used to assess localisation accuracy,
which can be considered easier to localise (longer stimu-
lus duration and stimuli with semantic meaning vs short-
time broad band noise). Galvin et al. [33] used a 12-speak-
er array for sound localisation arranged behind the subjects
and observed an improvement between 6.7 and 11.5° after
CI activation. Easier test conditions can be expected with
semicircular setups and fewer speakers that are positioned
in the front of the subjects. With a setup consisting of 11
speakers, an improvement of 37° was observed by Dillon
et al. [32]. Grossmann et al. [42] and Mertens et al. [36]
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used nine speakers and reported an improvement of 35.6°
and 44.1°, respectively. Arndt et al. [51] tested 45 subjects
with SSD in a semicircular setup consisting of seven loud-
speakers positioned in front of the subjects. The mean ab-
solute error improved by 13.5° after CI activation (com-
pared with 10.2° in our study). We could not see a clear
tendency for better localisation performance in participants
with preserved residual hearing compared with participants
with no residual hearing. However, localisation accuracy
decreased after implantation in just one patient who lost
residual hearing, demonstrating the importance of perse-
vering residual hearing capabilities during surgery. All oth-
er participants improved.
Even though speech understanding in noise and sound lo-
calisation after CI implantation were not comparable to
the abilities of the normal hearing control participants, the
global improvement and the regular use of the CI for more
than 11 hours per day in 9 of 10 patients demonstrates that
the majority of patients with SSD profit from it.
Limitations of this study included an unexpectedly long
recruiting duration because of refusal of many patients to
participate, and an imbalance between the participant cen-
tres. Bern contributed one patient only. The major limita-
tion of this study may have been that only five patients per
deaf side could be included. We will investigate further the
effect of the laterality, but preliminary results did not re-
veal side difference in our small sample. Deafness of one
ear induces multiple changes of neural plasticity in cen-
tral auditory pathways. As the left and right hemispheres
are specialised for different auditory tasks, a right- or left-
sided deafness could have different consequences. The left
auditory cortex and hemisphere show advantages for
speech understanding, whereas the right auditory cortex
and hemisphere are more involved in music perception and
sound localisation. Additional studies investigating the lat-
erality of deafness with respect to speech understanding in
noise and sound localisation may be needed. To enable ef-
fective data collection and comparability of outcome mea-
sures, and thus to get firm statements ensuring clinical
quality control in Switzerland, we suggest implementing
standardised minimum outcome measures for SSD patients
undergoing CI surgery [1]. This applies in particular for
sound field audiometry, including speech in noise and
sound localisation tests, where the broad range of mea-
surement conditions and experimental setups impedes data
pooling. The successfully operating Swiss CI database
(CICH) [66] will provide an efficient and solid framework
for such data collection.
To conclude, our SSD patients showed a significant im-
provement in quality of life, tinnitus perception, speech
understanding in noise and sound localisation. Our results
confirmed those reported previously in the literature. Ad-
ditionally, we found that the general quality of life of pa-
tients with SSD significantly increased after CI implanta-
tion to a level comparable to the normal hearing control
group. Cochlear implantation should be offered to adult pa-
tients with recently acquired SSD. However, the benefit of
CI implantations in congenital and early acquired SSD, or
SSD of long-time duration (more than 10 years) [67] is still
matter of debate.
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